UroGen Pharma (NASDAQ:URGN) stock in focus as company acquires oncolytic virus ICVB-1042 from IconOVir Bio, to design ...

UroGen Pharma has opened another front in its attack on bladder cancer, paying IconOVir Bio $4 million in stock for an ...

It’s hard to say something nice about viruses, but Dr. Joaquín Martínez Martínez can. Dr. Martínez Martínez is a new aquatic ...

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish ...

The Human Virome Program will analyze samples from thousands of volunteers in an effort to understand how viruses affect health.

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic ...

The virus is related to the pathogen that causes Middle East respiratory syndrome and capitalizes on the same ‘entry receptor ...

The study reveals that reducing the activity of the CUL5 gene helps CAR-T cells ... Influenza A Viruses Adapt Shape in Response to Environmental Pressures Feb. 10, 2025 — Influenza A virus ...

Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

The viruses used in virotherapy are called oncolytic viruses. An oncolytic virus kills a cancer cell by replicating inside cancer cells and breaking them open. The cancer-related antigens are then ...

The H5N1 virus, which made its way to the United States in 2022, has infected or killed millions of birds and infected many other animals In just the last three months, more… ...